drugset / Trial / NCT03500939
Penumbral Rescue by Normobaric O2 Administration in Patients With Ischemic Stroke and Target Mismatch ProFile
Phase 2
Terminated
223 enrolled
University Hospital Tuebingen
CORE BIOMARKER LABORATORY: Fundatio Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain · collabCORE IMAGING LABORATORY: Eppdata GmbH, 22529 Hamburg, Germany · collabEuropean Clinical Research Infrastructure Network (ECRIN), 10559 Berlin, Germany · collabHeinrich-Heine University, Duesseldorf · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objective of the PROOF trial is to investigate efficacy and safety of normobaric hyperoxygenation (NBHO) as a neuroprotective treatment in patients with acute ischemic stroke due to large vessel occlusion likely to receive endovascular mechanical thrombectomy (TBY) in a randomized controlled clinical phase IIb trial.
Timeline
- Start
- 2019-08-01
- Primary completion
- 2022-05-16
- Completion
- 2022-08-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxygen | Other / unclassified | 100 % | Inhaled |